Profile data is unavailable for this security.
About the company
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.
- Revenue in USD (TTM)30.89bn
- Net income in USD4.62bn
- LocationMedtronic PLC20 On Hatch, Hatch Street LowerDUBLIN 2IrelandIRL
- Phone+353 14381700
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|MDT:NYQ since |
|Stimgenics LLC||Deal completed||08 Jan 2020||08 Jan 2020Deal completed||4.07%||--|
|Klue Labs Inc||Deal completed||17 Dec 2019||17 Dec 2019Deal completed||4.02%||--|
|Titan Spine Inc||Deal completed||09 May 2019||09 May 2019Deal completed||33.87%||--|
|Advanced Cardiac Therapeutics Inc||Announced||24 Jan 2019||24 Jan 2019Announced||36.70%||--|